OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
17
Results
Show all
Save search
Copy query
Show results for
Unknown
(17)
Publication Date
Release Date
2023
(3)
2019
(3)
2025
(2)
2020
(2)
2016
(2)
2024
(1)
2022
(1)
2018
(1)
2017
(1)
2013
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Serum IgG Is Associated With Risk of Melanoma in the Swedish AMORIS Study.
Not available
S-EPMC6828930
|
biostudies-literature
Cite
In Planta
Glycan Engineering and Functional Activities of IgE Antibodies.
Not available
S-EPMC6781838
|
biostudies-literature
Cite
Basophils from Cancer Patients Respond to Immune Stimuli and Predict Clinical Outcome.
Not available
S-EPMC7408103
|
biostudies-literature
Cite
IgG subclass switching and clonal expansion in cutaneous melanoma and normal skin.
Not available
S-EPMC4944184
|
biostudies-literature
Cite
Regulatory B cell repertoire defects predispose lung cancer patients to immune-related toxicity following checkpoint blockade.
Not available
S-EPMC9174492
|
biostudies-literature
Cite
Immune mediator expression signatures are associated with improved outcome in ovarian carcinoma.
Not available
S-EPMC6492968
|
biostudies-literature
Cite
Investigating the association between allergen-specific immunoglobulin E, cancer risk and survival.
Not available
S-EPMC4938379
|
biostudies-literature
Cite
IgG4 subclass antibodies impair antitumor immunity in melanoma.
Not available
S-EPMC3613918
|
biostudies-literature
Cite
Anti-EGFR Antibody-Drug Conjugate Carrying an Inhibitor Targeting CDK Restricts Triple-Negative Breast Cancer Growth.
Not available
S-EPMC11292198
|
biostudies-literature
Cite
Anti-cancer pro-inflammatory effects of an IgE antibody targeting the melanoma-associated antigen chondroitin sulfate proteoglycan 4.
Not available
S-EPMC10130092
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets